多肽CRDMO平台
目录肽
您现在的位置：''标签解析异常!
索引超出了数组界限。
在 Whir.Label.Dynamic.Location.GetLocationInfo() 位置 E:\chenxz\05.ezEIP\ezEipV5.0\tags\V5.3.0(0649)\Whir.Label\Dynamic\Location.cs:行号 317 在 Whir.Label.Dynamic.Location.Render(HtmlTextWriter output) 位置 E:\chenxz\05.ezEIP\ezEipV5.0\tags\V5.3.0(0649)\Whir.Label\Dynamic\Location.cs:行号 103
索引超出了数组界限。
在 Whir.Label.Dynamic.Location.GetLocationInfo() 位置 E:\chenxz\05.ezEIP\ezEipV5.0\tags\V5.3.0(0649)\Whir.Label\Dynamic\Location.cs:行号 317 在 Whir.Label.Dynamic.Location.Render(HtmlTextWriter output) 位置 E:\chenxz\05.ezEIP\ezEipV5.0\tags\V5.3.0(0649)\Whir.Label\Dynamic\Location.cs:行号 103
中肽生化目录肽版块全新呈现，致力于打造全球最全面的多肽供应平台！我们专业的学术团队将时刻追踪最新最热的研究动向，帮助您发现实际需求，并以最高质量标准提供您所需要的产品。我们将我们将不定期更新产品列表，为您最大限度地节约科研时间，敬请广大客户朋友关注！
OXYT-005A
(Arg8)-Vasotocin
H-Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly-NH2\n(Disulfide bond) \n\nTrifluoroacetate salt
H-Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly-NH2\n(Disulfide bond) \n\nTrifluoroacetate salt
Size：5
P1(RMB)：537
MW：1050.23
One letter sequence：CYIQNCPRG-NH2 (Cys & Cys bridge)
Molecular Formula：C43H67N15O12S2
Description：Vasotocin also named argiprestocin is the vasopressin analog produced in birds, amphibians and fish. The peptide shows antidiuretic as well as reproductive activities.
Literature Reference：F.L.Moore and C.A.Lowry, Comp. Biochem. Physiol. C, Pharmacol. Toxicol. Endocrinol., 119, 251 (1998)\nA.Jurkevich and R.Grossmann, Domest. Anim. Endcrinol., 25, 93 (2003)\nF.Toyoda et al., Horm. Behav., 44, 346 (2003)\nR.J.Balment et al., Gen. Comp. Endocrinol., 147, 9 (2006)
Cas：113-80-4
P1(RMB)：537
MW：1050.23
One letter sequence：CYIQNCPRG-NH2 (Cys & Cys bridge)
Molecular Formula：C43H67N15O12S2
Description：Vasotocin also named argiprestocin is the vasopressin analog produced in birds, amphibians and fish. The peptide shows antidiuretic as well as reproductive activities.
Literature Reference：F.L.Moore and C.A.Lowry, Comp. Biochem. Physiol. C, Pharmacol. Toxicol. Endocrinol., 119, 251 (1998)\nA.Jurkevich and R.Grossmann, Domest. Anim. Endcrinol., 25, 93 (2003)\nF.Toyoda et al., Horm. Behav., 44, 346 (2003)\nR.J.Balment et al., Gen. Comp. Endocrinol., 147, 9 (2006)
Cas：113-80-4
